deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02628626

A Study of Colesevelam in Fecal Incontinence

A Placebo Controlled Study of Colesevelam in Fecal Incontinence

Sponsor: Mayo Clinic

Conditions Bile Acid Malabsorption Fecal Incontinence
Interventions Clonidine Colesevelam Placebo
Updated 12 times since 2017 Last updated: May 26, 2023 Started: Nov 30, 2015 Primary completion: Apr 14, 2022 Completion: Apr 14, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02628626, this PHASE3 trial focuses on Bile Acid Malabsorption and Fecal Incontinence and remains completed. Sponsored by Mayo Clinic, it has been updated 12 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshotRecruiting~Dec 2018 – ~Dec 2019 · 12 months · monthly snapshotRecruiting~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshotRecruiting~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotRecruiting~Jan 2022 – ~Sep 2022 · 8 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2023 · 10 months · monthly snapshotCompleted~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jul 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Sep 2022 — Jul 2023 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  5. Jan 2022 — Sep 2022 [monthly]

    Recruiting PHASE3

▶ Show 7 earlier versions

  1. Jan 2021 — Jan 2022 [monthly]

    Recruiting PHASE3

  2. Dec 2019 — Jan 2021 [monthly]

    Recruiting PHASE3

  3. Dec 2018 — Dec 2019 [monthly]

    Recruiting PHASE3

  4. Sep 2018 — Dec 2018 [monthly]

    Recruiting PHASE3

  5. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE3

  6. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mayo Clinic
  • National Center for Research Resources (NCRR)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations